Spotlights

New updated Pitch, Memorandum and Scenario Valuation 2023 for download. Auxesis Pharma Pitch 2023 Download here Auxesis Pharma Memorandum 2023 Download here Auxesis Pharma Scenario

Document regarding registration of sharholders deposit information is available for download in the Investor Hub.

Valuation AUXESIS 03/2023 Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is

Investor Invitation We are excited to invite you to our first Investor Forum monday the 30th of january at the Karolinska Institute, Huddinge, Sweden. On

News Euroclear Sweden AUXESIS PHARMA HOLDING AB (publ) register of shareholders is in process of being digitalised and transferred to the Euroclear system. As a client

Update There is exciting news in Auxesis Pharma. Trademarks, new areas of application, clinical studies and trials, production facilities, to name a few. Complete pdf

Do you want to join the journey? AUXESIS PHARMA HOLDING AB (publ) is increasing its stock with maximum 600.000 shares at a price of SEK 59 sek/share. Click below and you will

AUXESIS PHARMA HOLDING AB (publ) is now registered with the Swedish Companies Registration Office as a Public Limited Company (PLC) with a share capital of SEK 500,000. A

Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is now available. One-Pager

The shareholders in 559195-6486 AUXESIS PHARMA HOLDING AB (publ), is hereby convened to the Annual General Meeting on June 10, 2022 at 15.00 in the conference